Bulletin
Investor Alert

Market Pulse Archives

May 24, 2022, 8:59 a.m. EDT

INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    INmune Bio Inc. (INMB)
  • X
    iShares Biotechnology ETF (IBB)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of INmune Bio Inc. /zigman2/quotes/206182062/composite INMB +5.82% plummeted 31.4% toward a 22-month low in premarket trading Tuesday, after the Florida-based biotechnology company said it received an email from U.S. Food and Drug Administration, saying that it placed the Investigational New Drug (IND) application to initiate its Phase 2 trial of its XPro Alzheimer's treatment on clinical hold. Also in the email, the FDA requested additional information around Chemistry Manufacturing and Controls (CMC) regarding the company's newly manufactured XPro1595. The company said the Phase 2 trial of XPro remains open in Australia. B. Riley analyst Mayank Mamtani followed by downgrading the company to neutral from buy, and halved his stock price target to $7 from $14, citing indications from the company of "limited visibility to the required corrective measures and magnitude of potential delay." The stock, which is on track to open at the lowest level seen during regular-session hours since July 2020, has plunged 66.8% year to date through Monday, while the iShares Biotechnology ETF /zigman2/quotes/206189322/composite IBB +2.20% has dropped 23.7% and the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.16% has lost 16.6%.

/zigman2/quotes/206182062/composite
US : U.S.: Nasdaq
$ 9.28
+0.51 +5.82%
Volume: 69,615
July 5, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$157.39 million
Rev. per Employee
$34,000
loading...
/zigman2/quotes/206189322/composite
US : U.S.: Nasdaq
$ 122.81
+2.64 +2.20%
Volume: 3.54M
July 5, 2022 4:15p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,831.39
+6.06 +0.16%
Volume: 2.51B
July 5, 2022 5:04p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.